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Renal perfusion and function in healthy African Americans. disease (ESRD) [1]. Despite the striking increased risk
Background. Despite their increased risk of nephropathy, of nephropathy, remarkably little information is avail-
remarkably little is known about renal perfusion and function able on renal function in healthy African Americans. Inin healthy African Americans.
this study, we compared renal perfusion and function inMethods. We enrolled 32 healthy African Americans and
healthy African Americans and Caucasians who werecompared renal perfusion and function in 82 age-matched
healthy Caucasians. Studies were performed on a diet con- studied on a fixed sodium and potassium intake, as these
taining 200 mmol of sodium and 100 mmol of potassium per are important determinants of renal perfusion.
day. In a separate study of 28 subjects, 10 African American We also took the opportunity to examine controland 18 Caucasians, the contribution of the renin-angiotensin
mechanisms. Ethnicity is associated with variation in ge-system was assessed by measuring renal hemodynamic re-
netic polymorphisms [2, 3] and recently has been impli-sponses to angiotension II (Ang II) and captopril.
Results. Although glomerular filtration rate (GFR) was simi- cated in variation in renal perfusion and function in other-
lar, renal plasma flow (RPF) was significantly less in age- wise healthy individuals [4] The renin-angiotensin system
matched African Americans (568 6 18) than Caucasians (620 6
(RAS) was selected because it makes such an important13 mL/min/1.73 m2, P 5 0.0063). After captopril, African
contribution to the control of renal perfusion in healthAmericans had a sevenfold greater vasodilator response and
a rise in RPF (35.3 6 4.9 vs. 4.9 6 12.4 mL/min/1.73 m2 in and disease [6–8] and because of recent insights into
African Americans and Caucasians, respectively, P , 0.028). possible genetic control mechanisms [9]. A common vari-
Ang II administration caused a significantly smaller vasocon- ant of the angiotensinogen (AGT) gene (methionine
strictor response in African Americans (Ang II-induced fall in
M235 replaced by threonine, T235) has been associatedRPF, 297 6 18 vs. 2150 6 9 mL/min/1.73 m2, P 5 0.05), and
with altered renal control mechanisms in Caucasiansangiotensin-converting enzyme (ACE) inhibition enhanced the
response to Ang II in African Americans significantly. [10], which is believed to reflect increased intrarenal
Conclusions. A reduction in RPF, blunting of the renal vas- formation of angiotensin II (Ang II). Blacks have a
cular response to Ang II, and an accentuated renal vasodilator higher prevalence of this TT polymorphism [11]. Weresponse to captopril, which in turn corrects the blunting of
hypothesized that an activated intrarenal RAS couldresponsiveness to Ang II, all suggest activation of the renin
contribute to the propensity of African Americans devel-system in apparently healthy African Americans. As PRA was
identical in Caucasians and African Americans, the findings oping ESRD, and used the response to an angiotensin-
suggest that it is the intrarenal-renin system that is activated converting enzyme (ACE) inhibitor and to angiotensin
in African Americans. This difference in normal control mecha- II (Ang II) to test our hypothesis.nisms could predispose to nephropathy.
METHODS
African Americans shoulder a disproportionate rate Subjects
of renal disease, mainly from hypertension and diabetes.
We studied 32 healthy African Americans (35 6 2.7In 1996, African Americans comprised 12.6% of the U.S.
years) and 82 healthy age-matched Caucasians (38.0 6population, yet contributed 29.8% to end-stage renal
1.8 years) in balance on a high-salt diet. All were free
of cardiovascular, renal, and endocrine disease. After an
outpatient evaluation, which included a history, physicalKey words: ethnicity and kidney function, ACE inhibition, angiotensin
II, race and kidney, hypertension, diabetes, renin system. examination, and appropriate laboratory studies, eligible
subjects were admitted to the protocol. The majorityReceived for publication July 11, 2000
of the subjects used no medication other than vitaminand in revised form September 6, 2000
Accepted for publication September 13, 2000 supplements. There were three patients who used ven-
talin and beclovent inhalers. All subjects were studiedÓ 2001 by the International Society of Nephrology
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Table 1. Baseline characteristics of the 114 healthy subjectsduring admission to a metabolic ward, the General Clini-
cal Research Center of Brigham and Women’s Hospital. African Americans Caucasians
Written informed consent was obtained from each sub- N 32 82
Age years 3563.0 3861.8ject, and the protocol was approved by the Human Sub-
MAP mm Hg 8961.7 8661.0jects IRB Committee.
BMI kg/m2 26.460.8b 23.960.4
Three days before admission, subjects were placed on Weight kg 79.863.4b 72.361.2
K1 mEq/L 4.160.1 4.160.1a high-salt diet (200 mmol sodium per day) and daily 24-
PRA ng/mL/hr 0.560.1 0.660.1hour urine collections taken for measurement of sodium,
Aldosterone ng/dL 5.461.0 4.760.3
potassium, protein, and creatinine excretion. Each sub- Urine Na1 mEq/24 hr 223613.7 21768.9
Urine K1 mEq/24 hr 5063.8c 7862.3ject was admitted 24 to 48 hours prior to the study day
RPF mL/min/1.73 m2 568618.2b 620612.8and was maintained on a 200 mmol sodium and 100
GFR mL/min/1.73 m2 11562.9 11161.8
mmol potassium constant isocaloric diet, with at least Filtration fraction % 2060.5a 1960.4
2500 mL of fluid intake. Subjects were studied when 24- aP , 0.05; bP , 0.01; cP , 0.0001
hour urine sodium was greater than 150 mmol.
Protocol sequence
Subjects fasted overnight and remained recumbent Statistical analysis
throughout the study. One intravenous catheter was The primary endpoint studied was the magnitude of
placed in each arm at least two hours before the study, change in RPF in response to captopril and exogenous
one for infusions and the other for blood drawing. Para- Ang II. All data are expressed as mean 6 SEM. Body
aminohippurate (PAH) and inulin were infused, and mass index (BMI) was calculated as weight (kg) divided
clearances reflected renal plasma flow (RPF) and glo- by height (m2). Mean arterial pressure (MAP) was calcu-
merular filtration rate (GFR), respectively, as described lated as diastolic pressure 1 (systolic 2 diastolic)/3. Sta-
previously [8]. Studies began at approximately 7 a.m. tistical differences in two sample data were assessed by
with a bolus and then continuous infusion of PAH and t-test or nonparametric (Wilcoxon rank sum test). The
inulin. Baseline PAH and inulin measurements were null hypothesis was rejected when the P value was less
made 60 minutes later. than 0.05.
A different group of 28 subjects, 10 healthy African
Americans (age 28 6 2 years) and 18 Caucasians (age
RESULTS30 6 2 years), participated in a more extensive protocol.
After baseline renal clearance measurements were made, The 32 African Americans and 82 Caucasians in this
study were all matched for age, mean arterial bloodAng II (Hypertensin, Ciba) was infused for 45 minutes
at 3 ng/kg/min. This dose was used because it has been pressure, serum electrolytes, and sodium balance, as re-
flected in 24-hour sodium excretion (Table 1). Plasmafound to influence RPF with minimal pressor effects.
Immediately following, each subject received a single renin activity and plasma aldosterone concentration
were not statistically different in African Americans andoral 25 mg dose of captopril, known to be at the top of
the renal vasodilator dose–response curve [12]. To assess Caucasians. The African Americans, on the other hand,
were significantly heavier.the effect of captopril on the tissue sensitivity to Ang
II, the Ang II infusion was repeated 90 minutes after Baseline RPF was significantly lower in African Amer-
icans (568 6 18 vs. 620 6 13 mL/min/1.73 m2, P , 0.03;captopril was given. RPF and GFR measurements were
made at baseline and at 45-minute intervals. Plasma re- Table 1). As age is a major determinant of renal perfu-
sion, the relationship between age and RPF in blacksnin activity (PRA) and aldosterone were measured at
baseline and at 90 minutes. Blood pressure was recorded and whites was examined (Fig. 1). The anticipated highly
significant negative relationship between age and RPFby an automatic recording device (Dinamap, Critikon)
at 15-minute intervals and at 2-minute intervals during in the 82 Caucasians was identified. Age accounted for
approximately one third of the variation in RPF over anthe Ang II infusion.
age range of 18 to 79 years in the Caucasians (r 5 0.58,
Laboratory procedures r2 5 0.336, P , 0.001). RPF also fell with age in the
African Americans (r 5 0.375, r2 5 0.141, P 5 0.035;Blood samples were collected on ice and spun immedi-
ately, and the plasma was stored at 2808C until the time Fig. 1B). The dashed line in Figure 1B represents the
line of the best fit for the Caucasians. In the blacks, 24of assay. Serum and urinary sodium and potassium levels
were measured using the ion-selective electrode. Serum of 32, or 75%, of the points fell below the line for the
Caucasians. Graphically, the age-related difference dis-creatinine, PAH, and inulin were measured by an autoa-
nalyzer technique [7]. PRA and aldosterone were mea- appeared at approximately age 70 years.
Baseline characteristics for the 28 subjects who partici-sured by radioimmunoassay [13].
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Table 2. Baseline characteristics of the 28 healthy subjects
African Americans Caucasians
N 10 18
Age years 27.562.4 29.661.9
MAP mm Hg 8864.8 8261.7
BMI kg/m2 28.261.4a 23.460.7
Weight kg 85.565.1c 68.762.5
K1 mEq/L 4.160.1 4.260.008
PRA ng/mL/hr 0.3660.05 0.3760.008
Aldosterone ng/dL 3.760.4 3.560.3
Urine Na1 mEq/24 hr 213620 258622
Urine K1 mEq/24 hr 36.463.7d 59.866.1
RPF mL/min/1.73 m2 517627b 600614
GFR mL/min/1.73 m2 11064 11866
Filtration fraction % 21.560.7 20.360.01
aP 5 0.002 blacks vs. whites
bP 5 0.0006 blacks vs. whites
cP 5 0.003 blacks vs. whites
dP 5 0.01 blacks vs. whites
Table 3. Renal hemodynamic response to captopril
African Americans Caucasians
Before After Before After
ACEI ACEI ACEI ACEI
RPF mL/min/1.73 m2 517627 555627 600614 605616
GFR mL/min/1.73 m2 11064 11064 11866 11164
Filtration fraction % 2260.7 2060.6 2060.01 2060.008
Fig. 1. (A) Relationship between age and renal plasma flow (RPF)
measured as para-aminohippurate (PAH) clearance in 82 Caucasians.
The anticipated highly significant negative relationship was found (y 5
774–4.1 x; r 5 0.58, f 5 41.1, N 5 82; P , 0.001). The dashed line
represents the line of best fit in the Caucasians. (B) Relationship be-
tween age and para-aminohippurate (PAH) clearance in healthy Afri-
can Americans. The solid line represents the line of best fit in the blacks.
Three quarters of the points in the blacks fall below the line of best fit
in Caucasians (y 5 654–2.46 x; r 5 0.38, f 5 4.9, N 5 32; P , 0.035).
The age-related difference disappears at approximately age 70.
Fig. 2. Renal vascular response to angiotensin-converting enzyme
(ACE) inhibition with captopril in healthy African Americans ( ) andpated in the detailed substudy are presented in Table 2. whites (j; P , 0.028 blacks vs. whites).
Again, the African Americans and Caucasians were not
statistically different with regards to age, MAP, plasma
K1, sodium excretion, PRA, aldosterone level, and GFR.
BMI and body weight again were higher in the African cantly different in the two groups (35.0 6 5 vs. 4.9 6
12.4 mL/min/1.73 m2, P , 0.028 for African AmericansAmericans. Although baseline GFRs were comparable,
RPF was again significantly lower in the African Ameri- and Caucasians, respectively; Fig. 2). With the significant
vasodilator response after captopril administration in thecans compared with Caucasians (517 6 27 vs. 600 6
14 mL/min/1.73 m2, P 5 0.006). blacks, RPF in the two groups became more similar (555 6
27 vs. 605 6 16 mL/min/1.73 m2). GFR did not changeAfter receiving captopril, the African Americans had
a significant rise in RPF (517 6 27 to 555 6 27 mL/min/ in either group in response to captopril. Although filtra-
tion fraction trended downward in the African Ameri-1.73 m2, P , 0.0001), while RPF in the Caucasians was
unchanged (600 6 14 to 605 6 16 mL/min/1.73 m2; cans after captopril, the fall did not reach significance
(Table 3). Ang II administration (Table 4) caused a sig-Table 3). The change in RPF from baseline was signifi-
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Table 4. Renal responses to Ang II before and after captopril
African Americans Caucasians
Before ACEI After ACEI Before ACEI After ACEI
DRPF to Ang II mL/min/1.73 m2 297.3617.6a 2116.8618.5b 2150.169.4 2128.7614
aP 5 0.007 DRPF to Ang II from baseline in African Americans vs. Caucasians before captopril
bP 5 0.049 DRPF to Ang II from baseline in African Americans before vs. after administration of captopril
namic studies that have been performed in African
Americans involve diseased kidneys [14, 15] This study
was designed to assess two linked hypotheses. Our first
hypothesis was that RPF would be reduced in apparently
perfectly healthy blacks. Our second hypothesis was that
this difference would reflect activation of the intrarenal
RAS. The data strongly support both hypotheses. RPF
was about 10% lower in healthy age-matched African
Americans than in Caucasian participants. Despite a sim-
ilar PRA in the African Americans, there was a signifi-
cant enhancement of the renal vasodilator response to
ACE inhibition with captopril in the African Americans,
even on the high-salt diet employed to suppress the circu-Fig. 3. Renal vascular response to Ang II in African Americans and
Caucasians before (h) and after ( ) captopril. Note that the Caucasians lating RAS.
had no significant difference in response with or without captopril. The The mechanism of this renal vasodilator response to
African Americans after captopril responded similarly to Ang II as the
captopril appears to have involved a reduction in AngCaucasians. *P , 0.007 DRPF to Ang II from baseline in African
Americans vs. Caucasians before captopril; 1P , 0.049 DRPF to Ang II formation, rather than a reduction in bradykinin deg-
II from baseline in African Americans before vs. after administration radation, and thus prostaglandin and nitric oxide forma-
of captopril.
tion. This conclusion is based on the pattern of responses
to Ang II. Prior to captopril administration, the renal
vascular response to Ang II was blunted in African
Americans. We used as probes the RPF response tonificantly blunted vasoconstrictor response in the Afri-
exogenously administered Ang II and blockade of thecan Americans compared with the Caucasians (DRPF
RAS with captopril in high-salt balance. The limited297 6 18 vs. 2150 6 9 mL/min/1.73 m2, African Ameri-
response seen in the African Americans is similar tocans vs. Caucasians, respectively, P 5 0.007). After the
what we have experienced in healthy Caucasians in aadministration of captopril, the vasoconstrictor response
low-salt state [17] when the RAS is activated. Whento exogenously administered Ang II was enhanced sig-
given captopril at the top of its dose response for thenificantly in the African Americans (297 6 18 to 117 6
kidney [12], African Americans experienced sevenfold19 mL/min/1.73 m2, P 5 0.0488; Fig. 3), whereas the
more vasodilation. As in previous studies incorporatingresponse was unchanged in the Caucasians. The subjects
a high-salt diet, Caucasians vasodilated little when givenwere all normotensive. Mean arterial pressure (MAP)
captopril [16] probably because their intrarenal RAS iswas 88 6 5 and 82 6 2 mm Hg in the African Americans
more suppressed. In accord, Ang II administration inand Caucasians, respectively (Table 2). Blood pressure
the presence of captopril showed an enhanced responsein response to captopril did not change significantly in
in African Americans. This response probably reflectseither African Americans (88 6 5 to 83 6 7 mm Hg)
increased local Ang II in the kidney. If the vasodilatoror Caucasians (82 6 2 to 82 6 2 mm Hg). The 24-hour
response to captopril had involved kinins or the otherurine collections, done to verify sodium balance, were
vasodilator pathways, the consequence would have beenalso collected for protein measurements. All of the
a further blunting of the renal vascular response to Angsubjects had protein excretion of less than assay range
II [18]. The potentiation of the renal vasoconstrictor(,60 mg/dL).
response to Ang II after captopril, in this context, pro-
vides strong evidence that a reduction in Ang II forma-
DISCUSSION tion was the dominant mechanism responsible for the
Although the prevalence of renal disease is increased renal vasodilator response to captopril in healthy African
in African Americans, we can find no report on renal Americans. A difference in salt intake is unlikely to
account for these differences in the control of the renalhemodynamics in healthy blacks. The few renal hemody-
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circulation by ethnicity, as all studies were performed RPF, does not reflect intrarenal events. Although the
African Americans in this study were not morbidlyon a metabolic ward and on a controlled diet, and 24-
hour urine collections revealed an excretion rate that obese, their BMI was significantly higher than Cauca-
sians (P 5 0.04 in the group of 114 and 0.0002 in thewas essentially identical in the two groups. The sodium
in the diet is similar to the average sodium intake in the smaller cohort). To assess the issue of normalization to
body surface area, we also examined non-normalizedcommunity.
Hopkins et al reported that an AGT polymorphism values for RPF in mL/min. The vasodilator response to
captopril was still apparent (40 6 6 vs. 5 6 13 mL/minin which threonine replaces methionine at codon 235 is
associated with a blunted RPF response to infused Ang for African Americans vs. Caucasians, P 5 0.015). Al-
though the normalization did not appear to play a roleII in Caucasians and suggested that this may represent
increased intrarenal Ang II [10]. The frequency of this in our findings, more work is needed to investigate mech-
anisms of obesity-related renal responses.polymorphism is much higher in blacks [11] than Cauca-
sians. We hypothesized that African Americans there- Plasma renin levels were not statistically different in
the two groups, and not lower in the healthy Africanfore might have activation of the intrarenal RAS on the
same genetically determined basis. This, in turn, could Americans, as had been reported [22, 23]. As is the case
for the renal blood supply, we know a great deal aboutbe an underlying mechanism contributing to race-related
differences in renal disease. African American’s familial the state of the RAS in African Americans with hyper-
tension and renal disease and remarkably little aboutclustering of ESRD is more striking than in Caucasian
families [24, 25]. Polymorphisms of the AGT gene might the state and responsiveness of this system in healthy
blacks.be involved, as this polymorphism is associated with a
renal state resembling our findings in blacks, and this What mechanisms could be involved in the lower basal
RPF in healthy African Americans? We hypothesized apolymorphism is found at higher frequency in blacks
[11]. In blacks, obesity and consequent elevated insulin genetic factor, and that remains a possibility; however,
our research also uncovered a possible environmentallevels may also play a role in increasing AGT. We will
need studies in substantially more than 32 African Ameri- contributing factor: potassium. A reduction in potassium
intake has been described repeatedly in African Ameri-cans before assessment of the relationship of phenotype
to genotype is possible. cans [29]. We have shown an influence of dietary potas-
sium intake on the RAS, renal perfusion, and its responseBody mass index was higher in the African Americans
(Tables 1 and 2). Many studies have reported increased to Ang II that is relevant to this study. In healthy Cauca-
sians, a reduced potassium intake was associated with abody weight in African Americans [18]. African Ameri-
cans in our study showed lower basal RPFs compared significant increase in circulating renin activity, a signifi-
cant reduction in renal blood flow, and a decrease in thewith Caucasians. Chagnac et al found in normal, healthy,
severely obese individuals (BMIs of 43.8 6 1.0) that renal vascular response to infused Ang II, as we found
in blacks in this study. The potassium intake necessarythe RPF exceeded the controls by 31% [34]. Race was
not characterized. We found no correlation, however, to induce these measurable responses was very low, ap-
proximately 40 mmol/day [33]. Although potassium in-between body weight and response to captopril or Ang
II. It is becoming widely recognized that obesity plays take was controlled at the same high level in both Cauca-
sians and blacks in our study, this control period lastedsome role in the pathogenesis of hypertension and type
2 diabetes mellitus, and there may be a link between only one to two days, perhaps not long enough to replete
a deficiency. Serum potassium was identical in the twoobesity and altered renal function [10]. Obesity was
found to be a strong predictor of blunted renal responses groups, but 24-hour urine potassium excretion was sig-
nificantly lower in African Americans. Clearly, experi-to Ang II [10].
Renal mass varies with body size in adults [19]. There- ments in which a high potassium intake is maintained
for a longer interval will be important.fore, the need to normalize for body size has been intu-
ited. The standard practice has been to use a body surface Other hormones that can influence renal hemodynam-
ics are also possible contributors. The kallikrein-kininarea of 1.73 m2 [10, 20]. Depending on whether normal-
ization for body surface area was used, renal perfusion system has a vasodilator effect on the kidney. There is
evidence that renal kallikrein-kinins play a role in bloodcould be less than anticipated or exceed expectation in
the obese. To address this issue, Porter used radioactive pressure regulation and in the pathogenesis of hyperten-
sion [26, 27]. Urinary kallikrein excretion has been foundxenon to measure RBF in a group of lean and obese
healthy kidney donors [21]. Because blood flow as regis- to be decreased in hypertensives [28] and African Ameri-
cans [29, 30]. Some polymorphisms of the kallikrein genetered as mL/100 g/min with this method, no further ad-
justment for kidney or body size was necessary. As the have been identified predominantly in African Ameri-
cans [31]. Recently, genetic variability in one of the iso-obese subjects did not have a lower RPF, the normaliza-
tion procedure, which results in a reduction in apparent forms involved in the synthesis of nitric oxide has been
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with hypertension, non-insulin-dependent diabetes mellitus, andlinked to advanced nephropathy in type 1 diabetes melli-
coronary heart disease in Taiwan. Metabolism 46:1211–1214, 1997
tus [32]. Whether there is an increased prevalence of 4. Hollenberg NK, Rivera A, Meinking T, et al: Age, renal perfusion
and function in island-dwelling indigenous Kuna Amerinds of Pan-this polymorphism in blacks is unknown. More work is
ama. Nephron 82:131–138, 1999clearly required in the study of candidate genes related
5. Hollenberg NK, Williams G, Burger B, et al: The influence of
to renal disease. potassium on the renal vasculature and the adrenal gland, and
their responsiveness to angiotensin II in normal man. Clin Sci MolEthnicity as a contributor to differences in the fre-
Med 49:527–534, 1975quency of ESRD is widely recognized. Despite that rec-
6. Price DA, De’Oliveira JM, Fisher ND, et al: Renal hemodynamic
ognition, there has been remarkably little investigation response to an Ang II antagonist, eprosartan, in healthy men.
Hypertension 30:240–246, 1997into the environmental and genetic factors that might
7. Shoback DM, Williams GH, Moore TJ, et al: Defect in the sodium-contribute to such a difference. In Kuna Amerinds, for modulated tissue responsiveness to angiotensin II in essential hy-
example, a pattern of renal perfusion and GFR that pertension. J Clin Invest 72:2115–2124, 1983
8. Price DA, Porter LE, Gordon M, et al: The paradox of the low-differs striking from that in Caucasians has been de-
renin state in diabetic nephropathy. J Am Soc Nephrol 10:2382–scribed [4]. This study extends investigation into the pos- 2391, 1999
sibility that ethnicity contributes to differences in renal 9. Jeunemaitre X, Soubrier F, Kotelevtsev Y, et al: Molecular basis
of human hypertension: Role of angiotensinogen. Cell 71:169–178,perfusion and function in healthy blacks and whites. En-
1992
vironmental factors such as short-term sodium, potas- 10. Hopkins PN, Lifton RP, Hollenberg NK, et al: Blunted renal
vascular response to Ang II is associated with a common variantsium, and protein intake, body position, and time of day
of the AGT gene and obesity. J Hypertens 14:199–207, 1996are controlled easily on a metabolic ward and clearly
11. Rotimi C, Puras A, Cooper R, et al: Polymorphisms of renin-
contributed little or nothing to the difference in this angiotensin genes among Nigerians, Jamaicans, and African
Americans. Hypertension 27:558–563, 1996study. More long-term environmental factors involving
12. Hollenberg NK, Meggs LG, Williams GH, et al: Sodium intakediet or socioeconomic factors might participate through
and renal responses to captopril in normal man and in essential
mechanisms that are currently not recognized. hypertension. Kidney Int 20:240–245, 1981
13. Shoback DM, Williams GH, Hollenberg NK, et al: EndogenousThe triad of blunted vasoconstriction in response to
Ang II as a determinant of sodium modulated changes in tissueAng II, marked renal vasodilation with an ACE inhibi- responsiveness to Ang II in normal man. J Clin Endocrinol Metab
tor, and enhancement of vasoconstriction to Ang II after 57:764–770, 1983
14. Campese VM, Parise M, Karubian F, et al: Abnormal renal hemo-captopril—in the presence of a PRA level that is identical
dynamics in black salt-sensitive patients with hypertension. Hyper-to that in Caucasians—suggests increased levels of Ang tension 18:805–812, 1991
II in the kidneys of these individuals. African Americans, 15. Tierney WM, McDonald CJ, Luft FC: Renal disease in hyperten-
sive adults: Effect of race and type I diabetes mellitus. Am J Kidneywith a lower RPF and an activated intrarenal RAS, might
Dis 13:485–493, 1989
thereby be at greater risk of ESRD than age-matched 16. De’Oliveira JM, Price DA, Fisher NDL, et al: Autonomy of the
renin system in type II diabetes mellitus: Dietary sodium and renalCaucasians. The susceptibility to renal injury would be
hemodynamic responses to ACE inhibition. Kidney Int 52:771–777,expressed when triggers such as hypertension, diabetes,
1997
or HIV infection are superimposed. 17. Fisher NDL, Price DA, Litchfield WR, et al: Renal response to
captopril reflects state of local renin system in healthy humans.
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